Stockscreener 앱 받기
43.37
1.84%
-0.82
Celcuity Inc 주식(CELC)의 최신 뉴스
Celcuity Announces Q2 2025 Earnings Date: Biotech's Financial Results and Conference Call Details Revealed - Stock Titan
Celcuity Inc. Schedules Release of Second Quarter 2025 Financial Results and Webcast/Conference Call - GlobeNewswire
Celcuity Inc. shares rise 3.71% intraday as Novartis considers deal for biotech Avidity Biosciences. - AInvest
Celcuity’s Promising Clinical Trial Results and Strong Buy Recommendation by Andrew Berens - TipRanks
Celcuity Inc. Stock Analysis and ForecastCapitalize on market momentum for maximum gains - Jammu Links News
What drives Celcuity Inc. stock priceMaximize gains with expert analysis - Jammu Links News
What are analysts’ price targets for Celcuity Inc. in the next 12 monthsNavigate the market with precision tools - Jammu Links News
What are the technical indicators suggesting about Celcuity Inc.Unlock exclusive trading strategies - Jammu Links News
What is the risk reward ratio of investing in Celcuity Inc. stockPhenomenal returns - Jammu Links News
Should I hold or sell Celcuity Inc. stock in 2025Get expert analysis on top stock picks - Jammu Links News
How does Celcuity Inc. compare to its industry peersRapid return acceleration - Jammu Links News
Is it the right time to buy Celcuity Inc. stockBuild a winning investment portfolio - Jammu Links News
Why is Celcuity Inc. stock attracting strong analyst attentionAchieve rapid wealth accumulation through smart investing - Jammu Links News
What markets is Celcuity Inc. expanding into Is GSUN stock a good long term investment option - Jammu Links News
Celcuity Completes $201.25 Million Convertible Notes Issuance - MSN
What is the dividend policy of Celcuity Inc. stockExceptional risk-adjusted gains - Jammu Links News
What institutional investors are buying Celcuity Inc. stockSwing Trade Outlook For Every Investor - jammulinksnews.com
Celcuity Raises $248.7 Million Through Stock and Notes - The Globe and Mail
Celcuity announces $225M combined offerings; shares down - MSN
Celcuity Inc. stock trend outlook and recovery pathMarket Momentum Signal Generator Shows Trends - metal.it
Celcuity Inc. shares fall 1.57% after-hours as Novartis' Leqvio® receives FDA label update. - AInvest
Celcuity Inc's Recent Stock Offering: A Strategic Move in the Biotech Sector - AInvest
How strong is Celcuity Inc. company’s balance sheetSmart Portfolio Data Feed For 2025 - Jammu Links News
Celcuity prices $248.7M debt, stock offerings - MSN
Insiders Favor These 3 High Growth Companies - Yahoo Finance
Celcuity Inc. shares fall 1.24% after-hours following Novartis Canada's Scemblix approval expansion. - AInvest
Celcuity Surges 4.68% on $423.7M Capital Raise as $250M Volume Ranks 486th - AInvest
Dalvey David sells Celcuity (CELC) stock worth $4.8 million - Investing.com Australia
Dalvey David sells Celcuity (CELC) stock worth $4.8 million By Investing.com - Investing.com India
Celcuity: Positive Phase 3 Wild-Type ABC Data With Gedatolisib Leads To End Of 2025 Catalyst - Seeking Alpha
Celcuity Inc. Announces Pricing of Concurrent Public - GlobeNewswire
Celcuity (CELC) Is Up 176.2% After Positive Phase 3 Breast Cancer Results — Has the Bull Case Changed? - simplywall.st
Celcuity Prices Public Offering Of 175 Mln, 2.75% Sr. Notes, And 1.84 Mln Shares At $38/Shr - Nasdaq
Celcuity prices $175 million convertible notes, $85 million stock offering - Investing.com Australia
Celcuity prices $175 million convertible notes, $85 million stock offering By Investing.com - Investing.com India
Form FWP Celcuity Inc. Filed by: Celcuity Inc. - StreetInsider
Celcuity Updates Loan Agreement and Launches $225M Offering for Biotech Firm - AInvest
Celcuity Announces Concurrent Public Offerings to Raise $258.75 Million - AInvest
Is Celcuity Inc. stock a good hedge against inflationQuick Gain Stock Watch With Indicators Reviewed - metal.it
Biotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments - Benzinga
Up 215% YTD, Should You Grab This Growth Stock Before It’s Too Late? - Barchart.com
AI Trend Models Suggest Bounce for Celcuity Inc.Watchlist for Smart Swing Trading Updated - metal.it
Celcuity's triple drug combo tops AstraZeneca's treatment in breast cancer trial - MSN
Short Term Trend Reversal in Celcuity Inc. PossibleAI Based High Gain Watchlist Scanner Shared - metal.it
Celcuity Shares Double After Landmark Breast Cancer Drug Trial Results - MSN
Celcuity Surpasses Analyst Target Price, Shares Trade at $36.79 - AInvest
Relay Therapeutics has positive read from Celcuity data, says Barclays - The Globe and Mail
Celcuity (CELC) Skyrockets 167% on Breast Cancer Treatment Trial - Insider Monkey
0.14%
0.27%
자본화:
|
볼륨(24시간):